Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation

Author(s):
Paquette, M.; Franca, L.R.; Teutsch, C.; Diener, H.C.; Lu, S.H.; Dubner, S.J.; Ma, C.S.; Rothman, K.J.; Zint, K.; Halperin, J.L.; Huisman, M.V. (0000-0003-1423-5348); Lip, G.Y.H.; Nieuwlaat, R.
Published
2017
Publication type
Article / Letter to editor
discontinuationnon-VKA oral anticoagulantoral anticoagulationstroke preventionvitamin K antagonist
Date issued
2017-09-26
Language
English
Is part of
Journal of the American College of Cardiology (2017), Vol. 70, no. 13, p. 1573-1583
hdl
1887/115776
doi
10.1016/j.jacc.2017.07.793